Literature DB >> 27830019

PTK6 promotes hepatocellular carcinoma cell proliferation and invasion.

Xiaohong Chen1, Bo Song1, Yuanlong Lin1, Lijun Cao1, Shiyan Feng1, Lin Zhang1, Fuxiang Wang1.   

Abstract

Protein tyrosine kinase 6 (PTK6) is a nonreceptor tyrosine kinase that plays a crucial role in some tumors. However, the role of PTK6 is still unknown in hepatocellular carcinoma (HCC). In this study, we demonstrated that the PTK6 expression was upregulated in HCC tissues compared with adjacent normal tissues. Moreover, PTK6 was upregulated in the HCC cell lines (Bel7402, Hep3B, SMMC7721 and HepG2) compared with the normal liver epithelial cell line (THLE3). Ectopic expression of PTK6 promoted SMMC7721 cell proliferation, colony formation and invasion. Moreover, inhibition PTK6 expression suppressed the SMMC7721 cell proliferation, colony formation and invasion. Overexpression of PTK6 suppressed ERK1/2 phosphorylated expression. These data suggested that PTK6 played an oncogene role in the development of HCC.

Entities:  

Keywords:  ERK1/2; Hepatocellular carcinoma; PTK6

Year:  2016        PMID: 27830019      PMCID: PMC5095328     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  36 in total

1.  Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.

Authors:  Stephanie Ma; Jessie Y J Bao; Pak Shing Kwan; Yuen Piu Chan; Carol M Tong; Li Fu; Na Zhang; Amy H Y Tong; Yan-Ru Qin; Sai Wah Tsao; Kwok Wah Chan; Si Lok; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2012-06-13       Impact factor: 22.682

2.  Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.

Authors:  Yoshiaki Mizuguchi; Susan Specht; Kumiko Isse; Eizaburo Sasatomi; John G Lunz; Toshihiro Takizawa; Anthony J Demetris
Journal:  J Hepatol       Date:  2015-03-12       Impact factor: 25.083

3.  Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion.

Authors:  Che-Hung Shen; Hsin-Yi Chen; Ming-Shien Lin; Fang-Yen Li; Cheng-Chi Chang; Min-Liang Kuo; Jeffrey Settleman; Ruey-Hwa Chen
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

4.  PTK6 regulates IGF-1-induced anchorage-independent survival.

Authors:  Hanna Y Irie; Yashaswi Shrestha; Laura M Selfors; Fabianne Frye; Naoko Iida; Zhigang Wang; Lihua Zou; Jun Yao; Yiling Lu; Charles B Epstein; Sridaran Natesan; Andrea L Richardson; Kornelia Polyak; Gordon B Mills; William C Hahn; Joan S Brugge
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

Review 5.  Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer.

Authors:  Yu Zheng; Angela L Tyner
Journal:  Eur J Clin Invest       Date:  2013-02-10       Impact factor: 4.686

6.  Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.

Authors:  Chaoqun Wang; Hua Zhao; Xiankun Zhao; Jiao Wan; Dayong Wang; Wanli Bi; Xinghong Jiang; Yuzhen Gao
Journal:  Tumour Biol       Date:  2013-08-06

7.  Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells.

Authors:  Gaofeng Fan; Guang Lin; Robert Lucito; Nicholas K Tonks
Journal:  J Biol Chem       Date:  2013-06-28       Impact factor: 5.157

8.  miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.

Authors:  Yi Zhang; Dayong Zheng; Yan Xiong; Chengbiao Xue; Gen Chen; Bibo Yan; Qifa Ye
Journal:  FEBS Lett       Date:  2014-04-03       Impact factor: 4.124

Review 9.  miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer.

Authors:  Andrew Fesler; Haiyan Zhai; Jingfang Ju
Journal:  Onco Targets Ther       Date:  2014-08-21       Impact factor: 4.147

10.  Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma.

Authors:  Zejun Lu; Chuanfu Zhang; Jiajun Cui; Qi Song; Ligui Wang; Jingbo Kang; Peng Li; Xiaofeng Hu; Hongbin Song; Jinliang Yang; Yansong Sun
Journal:  Oncol Rep       Date:  2013-11-28       Impact factor: 3.906

View more
  6 in total

1.  Widespread Dysregulation of Long Noncoding Genes Associated With Fatty Acid Metabolism, Cell Division, and Immune Response Gene Networks in Xenobiotic-exposed Rat Liver.

Authors:  Kritika Karri; David J Waxman
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

2.  Epigenetic Deregulation of Protein Tyrosine Kinase 6 Promotes Carcinogenesis of Oral Squamous Cell Carcinoma.

Authors:  Yi-Ping Hsieh; Ken-Chung Chen; Meng-Yen Chen; Ling-Yu Huang; An-Yu Su; Wei-Fan Chiang; Wen-Tsung Huang; Tze-Ta Huang
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

Review 3.  Targeting protein tyrosine kinase 6 in cancer.

Authors:  Milica B Gilic; Angela L Tyner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-09-18       Impact factor: 10.680

4.  PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression.

Authors:  Yaw-Dong Lang; Hsin-Yi Chen; Chun-Ming Ho; Jou-Ho Shih; En-Chi Hsu; Roger Shen; Yu-Ching Lee; Jyun-Wei Chen; Cheng-Yen Wu; Hsi-Wen Yeh; Ruey-Hwa Chen; Yuh-Shan Jou
Journal:  Nat Commun       Date:  2019-12-16       Impact factor: 14.919

5.  Interference of PTK6/GAB1 signaling inhibits cell proliferation, invasion, and migration of cervical cancer cells.

Authors:  Juan Li; Nan Yang; Xiaolei Tian; Linglong Ouyang; Man Jiang; Shufang Zhang
Journal:  Mol Med Rep       Date:  2022-07-27       Impact factor: 3.423

6.  Overexpression of PTK6 predicts poor prognosis in bladder cancer patients.

Authors:  Xue-Lian Xu; Yun-Lin Ye; Zhi-Ming Wu; Qiu-Ming He; Lei Tan; Kang-Hua Xiao; Rui-Yan Wu; Yan Yu; Jia Mai; Zhi-Ling Li; Xiao-Dan Peng; Yun Huang; Xuan Li; Hai-Liang Zhang; Xiao-Feng Zhu; Zi-Ke Qin
Journal:  J Cancer       Date:  2017-09-27       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.